2026

Articles
Title
Riding the Upcycles: OCBC's Picks of Defence, Aviation and Construction Plays
ANALYSTS SAY: Buy, Sell, Hold (14 Apr)
This Stock is Up 4X In 2 Years, and DBS Research now has a target price with 25% upside
ANALYSTS SAY: Buy, Sell, Hold (13 Apr)
iX Biopharma: Broker Issues Rare 5X Target. How Did It Arrive At That?
Why This Spin-Off Stock Rose 20+% After Phillip and DBS Initiated Coverage
ANALYSTS SAY: Buy, Sell, Hold (10 Apr)
NAM CHEONG: 70% of Fleet on Long-Term Charters, Analyst Target Prices At 10-11x PE
ANALYSTS SAY: Buy, Sell, Hold (9 Apr)
The Oiltek Upgrade: How Two Analysts Justify S$2.70+ Target Prices